Home/Filings/3/0001123292-21-001061
3//SEC Filing

Blue Horizon Enterprise Ltd 3

Accession 0001123292-21-001061

CIK 0001744659other

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 4:16 PM ET

Size

9.9 KB

Accession

0001123292-21-001061

Insider Transaction Report

Form 3
Period: 2021-06-21
Holdings
  • Common Stock

    (indirect: See Footnote)
    4,907,829
Holdings
  • Common Stock

    (indirect: See Footnote)
    4,907,829
Holdings
  • Common Stock

    (indirect: See Footnote)
    4,907,829
Holdings
  • Common Stock

    (indirect: See Footnote)
    4,907,829
Footnotes (1)
  • [F1]Blue Horizon Enterprise Ltd. ("Blue Horizon") is the direct owner of 2,346,298 shares of the issuer's common stock and Ezbon International Limited ("Ezbon") is the direct owner of 2,561,531 shares of the issuer's common stock. Skorpios Trust ("Skorpios") is the sole owner of each of Blue Horizon and Ezbon. Montrago Trustees Limited ("Montrago Trustees") is the corporate trustee of Skorpios Trust. Each of Blue Horizon and Ezbon disclaim beneficial ownership of the shares of the issuer's common stock held by the other, and each of Skorpios Trust and Montrago Trustees disclaim beneficial ownership of the issuer's securities except to the extent of their pecuniary interest therein.

Issuer

Akero Therapeutics, Inc.

CIK 0001744659

Entity typeother
IncorporatedVirgin Islands, British

Related Parties

1
  • filerCIK 0001869057

Filing Metadata

Form type
3
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:16 PM ET
Size
9.9 KB